Dual Task in Female Patients With Fibromyalgia
Investigation of the Relationship Between Dual Task With Physical and Psychosocial Factors in Female Patients With Fibromyalgia
1 other identifier
observational
80
1 country
1
Brief Summary
The aim of our study is to examine the relationship between dual task and physical and psychosocial factors in female patients with fibromyalgia. We will perform Dual Task Test, 6 min Walking Test, the Baecke Habitual Physical Activity Questionnaire, Multidimensional Fatigue Inventory-20, Tracking Test, General Self-Efficacy Scale the Toronto Alexithymia Scale, the Revised FM Impact Questionnaire, the Social Support Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 13, 2022
CompletedFirst Posted
Study publicly available on registry
January 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedSeptember 29, 2023
September 1, 2023
1 year
January 13, 2022
September 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dual Task Assessment
Timed Up and Go Test: Participants are required to get up from the chair without assistance from their arms, walk 3 meters as fast as possible without running, turn their backs, walk back to the chair, and sit without assistance from their arms. The dual-task condition is performed by counting aloud backwards by twos, starting with a random number greater than 100 while performing the tests. Test result is saved in seconds
5 minutes
Secondary Outcomes (8)
Functional capacity
15 minutes
Physical Activity Assessment
15 minutes
Fatigue Assessment
10 minutes
Self-Efficacy Assessment
10 minutes
Alexithymia Assessment
15 minutes
- +3 more secondary outcomes
Study Arms (2)
Women patients with fibromyalgia
women with fibromyalgia beween age 30-75
Control group
Healthy female volunteers aged 30-75 years
Interventions
Dual Task Test, 6 min Walking Test, the Baecke Habitual Physical Activity Questionnaire, Multidimensional Fatigue Inventory-20, Tracking Test, General Self-Efficacy Scale the Toronto Alexithymia Scale, the Revised FM Impact Questionnaire, the Social Support Scale.
Eligibility Criteria
\- Women Women Patients aged 30-75 years diagnosed with fibromyalgia by a rheumatologist according to criteria set by the American College of Rheumatology and healthy control group
You may qualify if:
- Women aged 30-75 years
- Patients diagnosed with fibromyalgia by a rheumatologist according to criteria set by the American College of Rheumatology
- Patients who can communicate effectively with study staff.
- Patients who have read, understood and signed the informed consent form
You may not qualify if:
- Those who are pregnant
- Participants who could not sit and stand in a chair even once, or climb stairs unaided
- Other rheumatic diseases and other severe somatic or psychiatric disorders such as cancer, severe coronary disease, or other serious somatic or psychiatric disorders such as schizophrenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İlknur Naz Gürşan
Izmir, 35620, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
January 13, 2022
First Posted
January 27, 2022
Study Start
November 1, 2021
Primary Completion
November 1, 2022
Study Completion
December 1, 2022
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share